Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-01-10

FDA Approved: HEPARIN SODIUM IN SODIUM CHLORIDE — Supplemental Application (B. Braun Medical Inc.)

View source ↗

Summary

FDA approves a supplemental application for HEPARIN SODIUM IN SODIUM CHLORIDE from B. Braun Medical Inc., expanding its labeling for anticoagulation indications…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEPARIN SODIUM IN SODIUM CHLORIDE (heparin sodium in sodium chloride)

Snippet

SUPPL AP for HEPARIN SODIUM IN SODIUM CHLORIDE (HEPARIN SODIUM IN SODIUM CHLORIDE)